Background -Severe paraquat poisoning
causes considerable morbidity and mortality. High doses of cyclophosphamide and dexamethasone have been used to treat patients with paraquat poisoning, but with mixed results. The use of pulse methylprednisolone and cyclophosphamide was investigated in the treatment of moderately severe paraquat poisoning. Methods -During a six-year period 87 patients with paraquat poisoning were admitted to hospital, of whom 33 had moderate to severe intoxication. Seventeen patients received conventional treatment and served as historical controls, and 16 received intravenous infusions of cyclophosphamide 1 g daily for two days and methylprednisolone 1 g daily for three days. Results -There were no differences between the groups in age, sex, severity of paraquat poisoning (as assessed by urine dithionite tests), or in the time elapsed from ingestion to presentation at hospital or to the beginning of haemoperfusion. No differences were seen in biochemical measurements on the third day after paraquat poisoning. The From July 1992 to June 1994 41 patients with paraquat poisoning were admitted, 16 of whom had moderate to severe poisoning and were admitted within 24 hours of ingestion and survived for more than three days. These were enrolled in the study and were treated with pulse therapy of cyclophosphamide and methylprednisolone. Thirteen patients with fulminant poisoning and 12 with mild poisoning were excluded. The control group comprised 17 patients with moderate to severe poisoning, who were admitted within 24 hours ofingestion and who survived for three days, of the total of 46 admitted with paraquat poisoning between July 1989 and June 1991. Eleven patients with fulminant poisoning who died within three days of intoxication and 18 patients with mild poisoning were excluded.
TREATMENT PROTOCOL After gastric lavage with normal saline, active charcoal in magnesium citrate solution was given to both groups of patients through a nasogastric tube to prevent further absorption of paraquat from the gastrointestinal tract. All patients were haemoperfused for eight hours within 24 hours of paraquat ingestion. In the treatment group all patients received 1 g cyclophosphamide daily for two days and 1 g methylprednisolone daily for three days following haemoperfusion. The infusions were administered over two hours. Arterial blood gas tensions, white cell count, serum creatinine levels, chest radiography, and liver function tests were regularly checked.
DEFINITIONS6
Patients were considered to have developed acute renal failure if the serum creatinine level rose above 130 pmol/l or hepatitis if serum alanine aminotransferase (ALT) levels were >70 U/l (normal value <35 U/l) or total bilirubin was >35 pmol/l. Patients were considered to be hypoxic if the arterial oxygen tension (Pao2) when breathing room air was <9 kPa.
DATA ANALYSIS
The measurements in the two groups were compared using unpaired t tests, and the outcome of the 33 patients in the two groups was compared by the x' and Fisher's exact tests. A p value of <0 05 was considered significant.
Results
Of the 33 patients enrolled in the study, most were young adults. All were suicidal and had ingested 24% liquid paraquat concentrate. There were no differences between the groups in age, sex, time elapsed from ingestion to arrival at the emergency room (6-41 (6 57) versus 6-00 (5 80) hours), the beginning of haemoperfusion (8-59 (7 38) versus 8-29 (5-69) hours) or the timing of urine paraquat tests following ingestion (7-00 (6 93) versus 6-21 (4.55) hours), and the severity of paraquat poisoning (seven "navy blue" and nine "dark blue" versus six "navy blue" and 11 "dark blue"). There was no difference in the incidence of acute renal failure, hepatitis, or hypoxia on the third day following paraquat ingestion in the two groups (table) .
The fatality rate was significantly lower in the treatment group (25%) than in the control group 12/17 (70-6%) (p <001, x2 test; corrected by Fisher's exact test, p <0.02). All fatalities were from respiratory failure.
Leucopenia (white blood count <3000) was the only major complication of pulse therapy and occurred in six of the 16 cases (37-5%), but in all spontaneous recovery was complete within one week. Pulse therapy was well tolerated, although minor complications including hair loss and acne were noted in some patients.
Discussion
These data suggest that pulse therapy with cyclophosphamide and methylprednisolone improves the prognosis of patients with moderate to severe paraquat poisoning. All deaths were from progressive respiratory failure and a reduction in inflammatory change in the lungs is the likely mechanism. There were no severe complications, which suggests that it is safe and well tolerated. Retrospective studies1 [1] [2] have shown that both plasma and urine concentrations ofparaquat within the first 24 hours of intoxication are good predictors of outcome. The absence ofplasma paraquat concentrations is a limitation ofthis study, but plasma paraquat levels fall very quickly after an overdose and an error of an hour in the estimate of the time of ingestion can mean a change in survival from 30% to 70%." The urine dithionite test can be performed easily and quickly, giving a reasonable guide to the severity of poisoning and likely prognosis4 at the time of admission.
In conclusion, our results suggest that pulse therapy with cyclophosphamide and methylprednisolone may be an effective and safe way to treat patients with moderate to severe paraquat poisoning as determined by the urine dithionite test. Prospective controlled studies are required to confirm this observation.
